Is Allopurinol tablets, USP, 100 mg, Rx, Caraco Pharmaceutical Laboratories, Ltd, Detroit, MI, 100 tablet bottles: NDC 57664-434-88 and 1000 tablet bottles: NDC 576644-434-18. recalled?

Low RiskFDA Drug

Caraco Pharmaceutical Laboratories, Ltd.: Lack of assurance products do not contain an additional drug ingredient.; Lack of assurance products do not contain an additional drug ingredient

Agency Publication Date: July 14, 2009

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 51882

Status: Resolved

Manufacturer: Caraco Pharmaceutical Laboratories, Ltd.

Manufactured In: United States

Units Affected: 29 products (8044 bottles; 5472 bottles; 874 bottles; 1892 bottles; 9455 bottles; 12,980 bottles; 4450 bottles; 4796 bottles; 24,444 bottles; 13,690 bottles; 311 bottles; 7,308 bottles; 8,726 bottles; 3,660 bottles; 38,314 bottles; 39,638 bottles; 2626 bottles; 5,093 bottles; 9937 bottles; 7612 bottles; 1,271 bottles; 888 bottles; 4656 bottles; 26,367 bottles; 9,580 bottles; 58,435 bottles; 36,923 bottles; 18,357 bottles; 45,334 bottles)

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.